Skip to main content
    Paid monthly and annual subscribers can read every Medi-Chi book online — including clinical references and the TCM Textbook · downloads sold separatelySee the libraryClinical Education Tool — This platform provides educational resources for TCM practitioners and students. It does not issue medical certificates, prescriptions, or clinical diagnoses.
    neurology

    Muscular dystrophy

    Also known as: Inherited muscular dystrophies, Dystrophic myopathies, Duchenne muscular dystrophy, Becker muscular dystrophy, Limb-girdle muscular dystrophy

    Muscular dystrophies comprise a group of hereditary myopathies characterised by progressive skeletal muscle degeneration and atrophy. Phenotypes vary regarding age of onset, muscle distribution, and cardiac or respiratory involvement. Duchenne muscular dystrophy involves a deficit of functional dystrophin, necessitating continuous multidisciplinary specialist intervention. Acupuncture and Chinese herbal medicine are strictly elective adjunctive modalities for symptomatic management; they do not facilitate dystrophin restoration or decelerate disease progression. Current literature lacks clinical trials establishing therapeutic efficacy for muscular dystrophy. Specifically, cited evidence involves molecular signatures in murine models [1] and reviews of dystrophin-restoring therapies [4], while records [2] and [3] pertain to unrelated pathologies. The traditional patterns described herein serve as assessment frameworks rather than genetic diagnoses or validated treatment protocols. All clinical and safety decisions require specialist verification, as these abstracts do not constitute clinical guidelines.

    Plain-English one-pager you can print or hand to a patient. Free, no sign-in needed.

    All clinical details on this page are for practitioner premium subscribers only.
    Checking your practitioner access
    Verifying your Medi-Chi access…

    Lifestyle & Diet

    • •Adhere to the activity protocol established by the neuromuscular team; avoid exercise induced exhaustion or activity performed through pain.
    • •Utilise all prescribed mobility aids and domiciliary modifications to conserve energy and mitigate fall risks.
    • •Maintain optimal nutritional status via dietician consultation and request a formal swallowing assessment if coughing occurs during deglutition.
    • •Ensure attendance at all scheduled cardiac, respiratory, and rehabilitation reviews, and comply with medical directives regarding immunisation and pharmacotherapy.

    Cautions & Contraindications

    See sources
    • •Do not stop prescribed corticosteroids, cardiac medicines, ventilatory support or disease-specific therapy for TCM care. Reference [4] explains systemic treatment complexity; it is not an interaction or withdrawal guideline.[]
    • •Defer elective needling when breathing, cardiac status or general condition is unstable and arrange medical assessment. Reference [4] supplies cardiac and diaphragm context only; this procedural precaution is not tested in the abstract.[]
    • •Do not introduce herbal products during gene therapy, immune complications or changing specialist treatment without the treating team's approval. Reference [4] discusses immunological burden, but provides no herb–therapy interaction data.[]

    When to reassess or seek care again

    See sources

    Record a patient-selected symptom score from 0–10, sleep disruption, activity tolerance within existing limits and adverse effects at baseline. Review after 2–4 weeks of any agreed adjunctive trial; discontinue if there is no meaningful symptom benefit or treatment adds fatigue. Do not interpret symptom improvement as disease modification. New weakness, falls, swallowing change or cardiopulmonary symptoms require prompt medical reassessment rather than waiting for review.

    Explore more diseases

    Sources & Further Reading

    Clinical guidance, red flags and safety notes on this page draw on the following current sources alongside the classical references above.

    1. Aging · 2026
    2. Frontiers in neurology · 2026
    3. Progress in neuro-psychopharmacology & biological psychiatry · 2026
    4. Frontiers in pharmacology · 2026

    Educational reference for licensed practitioners. Not a substitute for individual clinical assessment. Refer to conventional care for any red-flag or undiagnosed presentation.